Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J O'Doherty

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Nuclear Medicine Communications|October 6, 2006
Sentinel lymph node biopsy in differentiated thyroid cancer: standard of care or experimental tool?Domenico Rubello, Michael J O'Doherty
Current Opinion in Neurology|November 26, 2002
Neurofibroma and schwannomaRosalie E Ferner, Michael J O'Doherty
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2003
Limitations of PET for imaging lymphomaSally F Barrington, Michael J O'Doherty
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2002
Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer?Miguel Gorenberg, William A Hallett, Michael J O'Doherty
Plos One|May 5, 2015
False Discovery Rates in PET and CT Studies with Texture Features: A Systematic ReviewAnastasia Chalkidou, Michael J O'Doherty, Paul K Marsden
Physics in Medicine and Biology|June 14, 2011
Extension of a data-driven gating technique to 3D, whole body PET studiesPaul J Schleyer, Michael J O'Doherty, Paul K Marsden
Seminars in Nuclear Medicine|February 4, 2009
Opportunistic infection and nuclear medicineMichael J O'Doherty, Sally F Barrington, John L Klein
Nuclear Medicine Communications|January 13, 2006
PET and TNM: evolution or revolution?Heok K Cheow, N George Mikhaeel, Michael J O'Doherty
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2009
Radiopharmaceutical clinical trials - dose is more than sieverts and becquerelsJames R Ballinger, Stephen J Mather, Michael J O'Doherty
The Lancet. Oncology|August 4, 2004
Issues undermining provision of diagnostic imaging in the UKPeter J Ell, Michael J O'Doherty, Gary J R Cook
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Nuclear Medicine Communications|October 6, 2006
Sentinel lymph node biopsy in differentiated thyroid cancer: standard of care or experimental tool?Domenico Rubello, Michael J O'Doherty
Current Opinion in Neurology|November 26, 2002
Neurofibroma and schwannomaRosalie E Ferner, Michael J O'Doherty
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2003
Limitations of PET for imaging lymphomaSally F Barrington, Michael J O'Doherty
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2002
Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer?Miguel Gorenberg, William A Hallett, Michael J O'Doherty
Plos One|May 5, 2015
False Discovery Rates in PET and CT Studies with Texture Features: A Systematic ReviewAnastasia Chalkidou, Michael J O'Doherty, Paul K Marsden
Physics in Medicine and Biology|June 14, 2011
Extension of a data-driven gating technique to 3D, whole body PET studiesPaul J Schleyer, Michael J O'Doherty, Paul K Marsden
Seminars in Nuclear Medicine|February 4, 2009
Opportunistic infection and nuclear medicineMichael J O'Doherty, Sally F Barrington, John L Klein
Nuclear Medicine Communications|January 13, 2006
PET and TNM: evolution or revolution?Heok K Cheow, N George Mikhaeel, Michael J O'Doherty
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2009
Radiopharmaceutical clinical trials - dose is more than sieverts and becquerelsJames R Ballinger, Stephen J Mather, Michael J O'Doherty
The Lancet. Oncology|August 4, 2004
Issues undermining provision of diagnostic imaging in the UKPeter J Ell, Michael J O'Doherty, Gary J R Cook
Pageof 4